Research progress in radiopharmaceuticals targeting tumor immune microenvironment
10.3760/cma.j.cn321828-20230817-00023
- VernacularTitle:靶向肿瘤免疫微环境放射性药物研究进展
- Author:
Kai ZHU
1
;
Caiyun LIU
;
Wenbin XIN
;
Tingting LIU
;
Xu WANG
Author Information
1. 滨州医学院附属医院核医学科，滨州 256603
- Keywords:
Radiopharmaceuticals;
Immunotherapy;
Tumor microenvironment;
Trends
- From:
Chinese Journal of Nuclear Medicine and Molecular Imaging
2024;44(9):559-563
- CountryChina
- Language:Chinese
-
Abstract:
Immunotherapy has made breakthrough in the field of tumor treatment. How to accurately predict the response of tumor patients to immunotherapy in the early stage is currently a clinical challenge. Nuclear medicine molecular imaging provides a new technological means for early accurate diagnosis, treatment monitoring, early warning of recurrence and metastasis, and guidance for personalized treatment of diseases. Therefore, it plays an irreplaceable role in precise diagnosis and treatment of tumors and patient stratification. This article reviews the progress of molecular imaging research on immune cells and related targets within the tumor microenvironment.
